跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BMX-A
首页
药物
BMX-A
BMX-A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds and compositions as protein kinase inhibitors
US 2005222177 A1
申请人: IRM LLC
优先权: 2003
CN
US
5 件公开
US 2005159391 A1
申请人: IRM LLC
优先权: 2003
CN
US
4 件公开
US 7745437 B2
申请人: IRM LLC
优先权: 2005
CN
US
3 件公开
US 2010324062 A1
申请人: IRM LLC
优先权: 2006
CN
US
3 件公开
US 7846923 B2
申请人: IRM LLC
优先权: 2007
CN
US
3 件公开
US 2008188483 A1
申请人: IRM LLC
优先权: 2005
CN
US
2 件公开
US 2008300246 A1
申请人: IRM LLC
优先权: 2005
CN
US
2 件公开
US 2009181991 A1
申请人: IRM LLC
优先权: 2005
CN
US
2 件公开
US 2009069327 A1
申请人: IRM LLC
优先权: 2006
CN
US
2 件公开
US 2008113986 A1
申请人: IRM LLC
优先权: 2005
US
2 件公开
US 8101608 B2
申请人: WAN YONGQIN
优先权: 2005
US
2 件公开
CN 101031568 A
申请人: IRM LLC
优先权: 2004
CN
Substituted pyrrolo[2,3-d]pyrimidines and compositions as protein kinase inhibitors
US 8183248 B2
申请人: NAGLE ADVAIT
优先权: 2006
CN
US
3 件公开
Heterocyclic compounds and uses thereof
US 9464089 B2
申请人: ACEA BIOSCIENCES INC
优先权: 2014
US
3 件公开
US 10562918 B2
申请人: ACEA BIOSCIENCES INC
优先权: 2013
CN
US
2 件公开
5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors
US 2008227783 A1
申请人: IRM LLC
优先权: 2005
CN
US
2 件公开
PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEREOF
US 2010087464 A1
申请人: IRM LLC
优先权: 2006
CN
US
2 件公开
US 2010184765 A1
申请人: IRM LLC
优先权: 2008
CN
US
2 件公开
US 2011053932 A1
申请人: IRM LLC
优先权: 2008
CN
US
2 件公开
METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA
EP 3079682 A4
申请人: DANA FARBER CANCER INST INC
优先权: 2013
EP
WO
2 件公开
US RE50030 E
申请人: DANA FARBER CANCER INST INC
优先权: 2014
US
Methods and compositions for use of therapeutic T cells in combination with kinase inhibitors
US 11590167 B2
申请人: JUNO THERAPEUTICS INC
优先权: 2016
CN
US
2 件公开
Composition and method for treating a drug-resistant cancer
US 11980594 B2
申请人: NOVELWISE PHARMACEUTICAL CORP
优先权: 2021
CN
US
2 件公开
BMX MOUSE MODELS FOR BECKER MUSCULAR DYSTROPHY (BMD) V
US 20250176510 A1
申请人: CHILDRENS NAT MEDICAL CT
优先权: 2022
US
WO
2 件公开
Compounds and compositions as inhibitors of receptor tyrosine kinase activity
US 2005124637 A1
申请人: IRM LLC
优先权: 2004
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈